SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment

Documenti analoghi

• In Silico, In Vitro, and In Vivo Antinociceptive Potential of S ‐Naproxen Derivatives
  di: Ubaidullah, et al.
  Pubblicazione: (2026)
• NANOBIOCATALYSTS FOR BIOFUEL CELLS AND BIOSENSOR SYSTEMS
  di: Radivoje Prodanović M.
  Pubblicazione: (2011)
• Drug Repurposing Investigation for Combating Ebola Virus Disease: Database Mining, Docking Calculations, Molecular Dynamics, and Density Functional Theory Study
  di: Alaa H. M. Abdelrahman, et al.
  Pubblicazione: (2025)
• Design, Synthesis, Biological Evaluation, and In Silico Study of Tetrahydropyridines as Prospective Monoamine Oxidase Inhibitors
  di: Obaid ur Rehman Khan, et al.
  Pubblicazione: (2025)
• Flavonoid Inhibition of Bacillus licheniformis LP‐8 Lipase: In Vitro and In Silico Insights Into Anti‐Obesity Potential
  di: Songul Bayrak, et al.
  Pubblicazione: (2026)